Dr. Alma Gedvilaitė

Phone: +370 5 2234359 
Email:

ORCID
ResearchGate

Projects and Grants:

Since 2022 participates in project „Genetic and molecular analysis of the role of Tbx5a in heart regeneration“ (grant No. 09.3.3-LMT-K-712-17-0014),
2021–2022.
VU coordinator of the project “Genetic mutations of Sars-CoV2 virus detection study in Lithuania”, established by the Decision No. V-221 as of 04 February 2021of the Minister of Health “On organizing, coordinating and investigating in-deph testing of Sars-CoV-2 in the process of detecting genetic mutations”
As PI and coordinator led Lithuanian national grants:
2017–2020 - researcher groups project “Investigation of K.lactis mutations conferring enhanced secretion phenotype and generation of yeast strains for supersecretion of recombinant proteins” (Nr. S-MIP-17-88);
2013–2015 - joint research programme project "Development of New Generation Means for Virus Diagnostics and Prophylaxis and Application in Veterinary Medicine" (grant VP1-3.1-ŠMM-10-V-02-017);
2012–2015 - activity 1.1.2. "Recombinant proteins for diagnostics of human pathogens" which was part of national complex programme "Biotechnology and Biopharmacy: Fundamental and Applied Research" led by prof. K. Sasnauskas. (grant No. VP1-3.1-SMM-08-K01-005);
2007–2009 - project of Industrial Biotechnology: "Engagement of metagenomic analysis of extremophile viruses from hot underground waters of Lithuania searching for the new enzymes” (N-22/2009 and PBT-02/2009);
2006–2007 - project "Design, construction, expression and purification of chimeric virus-like particles for generation of monoclonal antibodies against inserted peptides" (No. G-82/06 and G-03/07);
2006 - project "Possibilities of expression of functional recombinant human single-chain MHC-peptide molecules in yeast" (No. T-1/06);
2003–2005 - project “Human tumor vaccine based on chimeric virus-like particles“ (No. V-11, V-20 and V-30);
2002 - project "Investigation of biological functions of UK114 and its human homologue hp14.5 in S. cerevisiae" (No. G-053);
1998 - project “Creation and analysis of artificial yeast prion”.
Participated in:
2009–2010 - project "Development of diagnostic tools for Merkel cell polyoma virus" (Nr. N-22/2009 and PBT-02/2009);
2013–2015 - two global grant measure projects "The Use of Genome-Wide Analysis for Engineering of New Yeast Strains with Improved Heterologous Expression" (VP1-3.1-SMM-07-K-02-038) and "Novel Chimeric Proteins with Antiviral Activity" (VPI-3.1-SMM-07-K-02-03).
Participated in projects funded by EU Commission ES FP5, FP6, and BP7:
2000–2003 - QLK2-CT-1999-1119. Hantavirus vaccine for Europe;
2001–2003 - project QLK2-2000-01476. Combined immune and gene therapy for chronic viral hepatitis;
2001–2004 - project QLK2-CT-2001-01632. Enhanced laboratory surveillance of measles;
2005–2008 - project COMPUVAC (Rational design and standardized evaluation of novel genetic vaccines);
2010–2013 - project “Strengthening and Sustaining the European Perspectives of Molecular Biotechnology in Lithuania (MoBiLi)”.
Participated as coordinator from BTI in projects with Humboldt University Institute of Virology funded by the German Ministry of Education, Science, Research and Technology:
2002–2005 - WTZ-02-001 "Human tumour vaccine based on chimeric virus-like particles";
2000–2003 - WTZ-00-001 "Hantavirus vaccine based on recombinant virus proteins"
1998–2000 - WTZ-97-002 "Virus-like particles used to create vaccines".
Led the projects funded by industry:
2017 - project "Cloning and expression of KEX2 proteinase in yeast Saccharomyces cerevisiae" (No. 31V-60) funded by UAB “Profarma”;
2010 - project "Design, construction, expression and purification of chimeric virus-like particles for generation of monoclonal antibodies against inserted peptides" (No. 1223) funded by UAB "Fermentas";
2006–2007 - project "Design, construction, expression and purification of chimeric virus-like particles for generation of monoclonal antibodies against inserted peptides" (No. 05-407/06) funded by UAB "Fermentas";
2002 - project "Investigation of biological functions of UK114 and its human homologue hp14.5 in S. cerevisiae" (No. 28/01) funded by UAB "Biotechna".